Cano Health, Inc.

EDGAR

30 filing records in this dataset, filed from 2020-04-28 to 2024-05-10. Reported financial figures are available; chart coverage varies by period.

Watchlist

Latest quarter

Revenue

684 million USD

2024 Q1 · USD

Exact inputs and evidence

Operating margin

-16.23%

2024 Q1 · %

Exact inputs and evidence
  • Operating Income: -111110000 USD Source
  • Revenue: 684426000 USD Source

Operating cash flow

-48.8 million USD

2024 Q1 · USD

Exact inputs and evidence
  • Operating Cash Flow: -48828000 USD Source

Free cash flow

-49.6 million USD

2024 Q1 · USD

Exact inputs and evidence
  • Operating Cash Flow: -48828000 USD Source
  • Capital Expenditure: 814000 USD Source
Cash and cash equivalents
488 thousand USD Source
Exact value

487743 USD

Long-term debt including current maturities
0 USD Source
Exact value

0 USD

Shares outstanding
Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

2.96 billion USD

2023-04-01 – 2024-03-31

Exact inputs and evidence
  • Revenue: 766746000 USD · 2023-04-01 – 2023-06-30 Source
  • Revenue: 788073000 USD · 2023-07-01 – 2023-09-30 Source
  • Revenue: 3137757000 USD · 2023-01-01 – 2023-12-31 Source
  • Revenue: 2421729000 USD · 2023-01-01 – 2023-09-30 Source
  • Revenue: 684426000 USD · 2024-01-01 – 2024-03-31 Source

Capital expenditure

15 million USD

2023-04-01 – 2024-03-31

Exact inputs and evidence
  • Capital expenditure: 11270000 USD · 2023-01-01 – 2023-06-30 Source
  • Capital expenditure: 5080000 USD · 2023-01-01 – 2023-03-31 Source
  • Capital expenditure: 18139000 USD · 2023-01-01 – 2023-09-30 Source
  • Capital expenditure: 11270000 USD · 2023-01-01 – 2023-06-30 Source
  • Capital expenditure: 19233000 USD · 2023-01-01 – 2023-12-31 Source
  • Capital expenditure: 18139000 USD · 2023-01-01 – 2023-09-30 Source
  • Capital expenditure: 814000 USD · 2024-01-01 – 2024-03-31 Source

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2024-05-10.

Financial data available through: 2023-12-31.

Coverage by financial measure
  • Revenue: 5 of 11 periods available· newest 2023-12-31
  • Operating income: 5 of 11 periods available· newest 2023-12-31
  • Net income: 4 of 11 periods available· newest 2023-12-31
  • Operating cash flow: 5 of 11 periods available· newest 2023-12-31
  • Capital expenditure: 5 of 11 periods available· newest 2023-12-31
  • Total assets: 5 of 11 periods available· newest 2023-12-31
  • Total liabilities: 5 of 11 periods available· newest 2023-12-31
  • Current assets: 4 of 11 periods available· newest 2023-12-31
  • Current liabilities: 5 of 11 periods available· newest 2023-12-31
  • Cash and cash equivalents: 1 of 11 periods available· newest 2020-12-31
  • Long-term debt including current maturities: 3 of 11 periods available· newest 2023-12-31
  • shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Revenue

    +14.6%

    Prior period

    USD 2.74 billion

    –

    Current period

    USD 3.14 billion

    –

    Exact inputs and evidence

    3137757000 − 2738916000 = 398841000 USD

    2738916000 USD · 2022-01-01 – 2022-12-31

    Inspect prior input Prior source

    3137757000 USD · 2023-01-01 – 2023-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Net income

    −USD 387.15 million

    Prior period

    −USD 207.27 million

    –

    Current period

    −USD 594.42 million

    –

    Exact inputs and evidence

    -594418000 − -207272000 = -387146000 USD

    -207272000 USD · 2022-01-01 – 2022-12-31

    Inspect prior input Prior source

    -594418000 USD · 2023-01-01 – 2023-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    +USD 17.29 million

    Prior period

    −USD 146.34 million

    –

    Current period

    −USD 129.05 million

    –

    Exact inputs and evidence

    -129049000 − -146337000 = 17288000 USD

    -146337000 USD · 2022-01-01 – 2022-12-31

    Inspect prior input Prior source

    -129049000 USD · 2023-01-01 – 2023-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Capital expenditure

    -61.2%

    Prior period

    USD 49.53 million

    –

    Current period

    USD 19.23 million

    –

    Exact inputs and evidence

    19233000 − 49529000 = -30296000 USD

    49529000 USD · 2022-01-01 – 2022-12-31

    Inspect prior input Prior source

    19233000 USD · 2023-01-01 – 2023-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2023 2023-01-01 – 2023-12-31

  • Revenue USD 3.14 billion 100% of revenue
  • Operating costs Derived USD 4.14 billion 132% of revenue
  • Operating income −USD 1 billion −32% of revenue
  • Tax, interest and other Derived −USD 410.01 million −13% of revenue
  • Net income −USD 594.42 million −19% of revenue

Cash

  • Operating cash flow −USD 129.05 million −4.1% of revenue
  • Capital expenditure USD 19.23 million 0.6% of revenue
  • Free cash flow Derived −USD 148.28 million −4.7% of revenue

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2019 Not shown: operating income or net income is not reported.
  • 2020 Operating loss: operating costs were 100% of revenue.
  • 2021 Operating loss: operating costs were 108% of revenue.
  • 2022 Operating loss: operating costs were 116% of revenue.
  • 2023 Operating loss: operating costs were 132% of revenue.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2019 2019-01-01 – 2019-12-31361384000 371070000 Derived -9686000 UnavailableUnavailable-24775000 Derived
Source
2020 2020-01-01 – 2020-12-31831576000 831816000 Derived -240000 28639692 Derived -28879692 -21307000 Derived
Source
2021 2021-01-01 – 2021-12-311609369000 1744556000 Derived -135187000 -117167000 Derived -18020000 -152387000 Derived
Source
2022 2022-01-01 – 2022-12-312738916000 3175716000 Derived -436800000 -229528000 Derived -207272000 -195866000 Derived
Source
2023 2023-01-01 – 2023-12-313137757000 4142185000 Derived -1004428000 -410010000 Derived -594418000 -148282000 Derived
Source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 3.1B 2023
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.3.4B2.5B1.7B847.2M0.020192020202120222023
Values and sources
Revenue values and source evidence
PeriodSeriesValue(USD)Source evidence
2019Revenue361384000
2020Revenue831576000
2021Revenue1609369000
2022Revenue2738916000
2023Revenue3137757000

Revenue growth

Change in revenue from the same financial period one year earlier.

14.6% 2023
Revenue growth historyChange in revenue from the same financial period one year earlier. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.141%105%70%35%0%20192020202120222023
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2019Year over yearNo prior comparable period
2020Year over year130.1%
2021Year over year93.5%
2022Year over year70.2%
2023Year over year14.6%

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -32% 2023
Net margin -18.9% 2023
Free cash flow margin -4.7% 2023
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.2.6%-6.7%-16.0%-25.3%-34.6%20192020202120222023
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2019Operating margin-2.7%
2020Operating margin-0%
2021Operating margin-8.4%
2022Operating margin-15.9%
2023Operating margin-32%
2019-12-31Net marginNot reported
2020Net margin-3.5%
2021Net margin-1.1%
2022Net margin-7.6%
2023Net margin-18.9%
2019Free cash flow margin-6.9%
2020Free cash flow margin-2.6%
2021Free cash flow margin-9.5%
2022Free cash flow margin-7.2%
2023Free cash flow margin-4.7%

Operating cash flow

Cash generated by the company’s normal business operations.

USD -129M 2023
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.11.7M-30.7M-73.2M-115.6M-158.0M20192020202120222023
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2019Operating cash flow-15465000
2020Operating cash flow-9235000
2021Operating cash flow-118033000
2022Operating cash flow-146337000
2023Operating cash flow-129049000

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -148.3M 2023
Free cash flow historyOperating cash flow minus capital expenditure for the same period and unit. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.15.7M-41.1M-97.9M-154.7M-211.5M20192020202120222023
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2019Free cash flow-24775000
2020Free cash flow-21307000
2021Free cash flow-152387000
2022Free cash flow-195866000
2023Free cash flow-148282000

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

152.8% 2023
Liabilities to assets historyTotal liabilities as a share of total assets. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.165%124%82%41%0%20192020202120222023
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2019Liabilities / assets111.6%
2020Liabilities / assets91.9%
2021Liabilities / assets62.7%
2022Liabilities / assets74.4%
2023Liabilities / assets152.8%

Current assets to current liabilities

Current assets divided by current liabilities.

0.13× 2023
Current assets to current liabilities historyCurrent assets divided by current liabilities. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.2.13×1.60×1.06×0.53×0.00×2019-12-312020202120222023
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2019-12-31Current assets / current liabilitiesNot reported
2020Current assets / current liabilities1.65×
2021Current assets / current liabilities1.97×
2022Current assets / current liabilities1.63×
2023Current assets / current liabilities0.13×

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2019 2019-01-01 – 2019-12-31
Unavailable Not reported for this period.
−USD 15.47 million
Exact value

Exact value: -15465000 USD

2019-01-01 – 2019-12-31: -15465000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 9.31 million
Exact value

Exact value: 9310000 USD

2019-01-01 – 2019-12-31: 9310000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 24.78 million
Calculation and evidence

-15465000 − 9310000 USD

Exact free cash flow: -24775000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2020 2020-01-01 – 2020-12-31
−USD 28.88 million
Exact value

Exact value: -28879692 USD

2020-01-01 – 2020-12-31: -28879692 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 9.24 million
Exact value

Exact value: -9235000 USD

2020-01-01 – 2020-12-31: -9235000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 12.07 million
Exact value

Exact value: 12072000 USD

2020-01-01 – 2020-12-31: 12072000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 21.31 million
Calculation and evidence

-9235000 − 12072000 USD

Exact free cash flow: -21307000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2021 2021-01-01 – 2021-12-31
−USD 18.02 million
Exact value

Exact value: -18020000 USD

2021-01-01 – 2021-12-31: -18020000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 118.03 million
Exact value

Exact value: -118033000 USD

2021-01-01 – 2021-12-31: -118033000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 34.35 million
Exact value

Exact value: 34354000 USD

2021-01-01 – 2021-12-31: 34354000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 152.39 million
Calculation and evidence

-118033000 − 34354000 USD

Exact free cash flow: -152387000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2022 2022-01-01 – 2022-12-31
−USD 207.27 million
Exact value

Exact value: -207272000 USD

2022-01-01 – 2022-12-31: -207272000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 146.34 million
Exact value

Exact value: -146337000 USD

2022-01-01 – 2022-12-31: -146337000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 49.53 million
Exact value

Exact value: 49529000 USD

2022-01-01 – 2022-12-31: 49529000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 195.87 million
Calculation and evidence

-146337000 − 49529000 USD

Exact free cash flow: -195866000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2023 2023-01-01 – 2023-12-31
−USD 594.42 million
Exact value

Exact value: -594418000 USD

2023-01-01 – 2023-12-31: -594418000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 129.05 million
Exact value

Exact value: -129049000 USD

2023-01-01 – 2023-12-31: -129049000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 19.23 million
Exact value

Exact value: 19233000 USD

2023-01-01 – 2023-12-31: 19233000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 148.28 million
Calculation and evidence

-129049000 − 19233000 USD

Exact free cash flow: -148282000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

30 filings · 1,227 latest values · 1,227 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001800682, 1800682, CANO, edgar:1800682

Also known as Cano Health, Inc., Jaws Acquisition Corp.